Cargando…
The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices enforce...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799842/ https://www.ncbi.nlm.nih.gov/pubmed/33428667 http://dx.doi.org/10.1371/journal.pone.0244722 |